Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics

No abstract is available for this paper.

• Publication year

  2017

• Venue

  AAPS PharmSciTech

• Publication date

  2017-11-06

• Fields of study

  Medicine, Chemistry, Mathematics

• Identifiers
  DOI 10.1208/s12249-017-0911-1PMID 29110294PMCID PMC6995279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of NMR and Dynamic Light Scattering for Measuring Diffusion Coefficients of Formulated Insulin: Implications for Particle Size Distribution Measurements in Drug Products

  2017cited by this paper
• Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.

  2016cited by this paper
• Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure.

  2016cited by this paper
• Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars

  2016cited by this paper
• Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance.

  2015cited by this paper
• The Mahalanobis distance and its relationship to principal component scores

  2015cited by this paper
• Marketplace Analysis of Conjugated Estrogens: Determining the Consistently Present Steroidal Content with LC-MS

  2015cited by this paper
• Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR

  2015cited by this paper
• Modern analytics for synthetically derived complex drug substances: NMR, AFFF–MALS, and MS tests for glatiramer acetate

  2015cited by this paper
• Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysis.

  2015cited by this paper
• On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods.

  2015cited by this paper
• NMR profiling of biomolecules at natural abundance using 2D 1H-15N and 1H-13C multiplicity-separated (MS) HSQC spectra.

  2015cited by this paper
• Post-translational structural modifications of immunoglobulin G and their effect on biological activity

  2014cited by this paper
• Heteronuclear NMR as a 4-in-1 analytical platform for detecting modification-specific signatures of therapeutic insulin formulations.

  2014cited by this paper
• Profiling formulated monoclonal antibodies by (1)H NMR spectroscopy.

  2013cited by this paper
• Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy.

  2013cited by this paper
• Characterization of currently marketed heparin products: composition analysis by 2D-NMR

  2013cited by this paper
• Characterization of currently marketed heparin products: key tests for LMWH quality assurance.

  2013cited by this paper
• Deep-Ultraviolet (UV) Resonance Raman Spectroscopy as a Tool for Quality Control of Formulated Therapeutic Proteins

  2012cited by this paper
• Developing the nation's biosimilars program.

  2011cited by this paper
• Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data

  2011cited by this paper
• Assessment of the effects of pH, formulation and deformulation on the conformation of interferon alpha-2 by NMR.

  2010cited by this paper
• Assessment of the three-dimensional structure of recombinant protein therapeutics by NMR fingerprinting: demonstration on recombinant human granulocyte macrophage-colony stimulation factor.

  2008cited by this paper
• Chemometric Approach in Quantification of Structural Identity/Similarity of Proteins in Biopharmaceuticals

  2007cited by this paper
• Review on Multiway Analysis in Chemistry—2000–2005

  2006cited by this paper
• Multiway chemometric analysis of the metabolic response to toxins monitored by NMR

  2005cited by this paper
• Novel Characterization of Proteomics Maps by Sequential Neighborhoods of Protein Spots

  2005cited by this paper
• Grouping three‐mode data with mixture methods: the case of the diseased blue crabs

  2004cited by this paper
• Methods of Multivariate Analysis, 2nd Ed.

  2004cited by this paper
• A graph theoretical characterization of proteomics maps

  2002cited by this paper
• Towards rapid and unique curve resolution of low-field NMR relaxation data: trilinear SLICING versus two-dimensional curve fitting.

  2002cited by this paper
• Flexibility and bioactivity of insulin: an NMR investigation of the solution structure and folding of an unusually flexible human insulin mutant with increased biological activity.

  2001cited by this paper
• Towards a standardized notation and terminology in multiway analysis

  2000cited by this paper
• Solution structures of the R6 human insulin hexamer,.

  1997cited by this paper
• Methods of multivariate analysis

  1995cited by this paper
• 1H, 13C and 15N chemical shift referencing in biomolecular NMR

  1995cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• An efficient algorithm for TUCKALS3 on data with large numbers of observation units

  1992cited by this paper
• Some mathematical notes on three-mode factor analysis

  1966cited by this paper

• Interpretable machine learning prediction of biochar characteristics based on laser-Raman spectroscopy.

  2026cites this paper
• An Automated Tool for Glycosimilarity Assessment of mAb Therapeutic Biosimilars: Trastuzumab and Bevacizumab as Case Studies

  2025cites this paper
• Impact of structure and formulation changes on the function of insulin products

  2025cites this paper
• NMR-based structural integrity analysis of therapeutic monoclonal antibodies: a comparative study of Humira and its biosimilars

  2025cites this paper
• Structural Similarity of Biological Drugs Using Statistical Signal Processing and Nuclear Magnetic Resonance Spectral Pattern Analysis.

  2025cites this paper
• First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product

  2024influential citation
• A multifaceted approach to understanding protein-buffer interactions in biopharmaceuticals.

  2024cites this paper
• NMR coupled with multivariate data analysis for monitoring the degradation of a formulated therapeutic monoclonal antibody.

  2024cites this paper
• Structural Relationships to Efficacy for Prazole‐Derived Antivirals

  2024cites this paper
• Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies

  2023cites this paper
• Assessment of computational approaches in the prediction of spectrogram and chromatogram behaviours of analytes in pharmaceutical analysis: assessment review

  2023cites this paper
• Best Practices for Submission of NMR Data to Support Higher Order Structure Assessment of Generic Peptide Drugs

  2023cites this paper
• 2D NMR peak profiling to compare chemical differences between batches of pentosan polysulfate sodium.

  2022cites this paper
• Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms

  2022cites this paper
• Taking the individual bias out of examining comparability of biosimilars: A case study on monoclonal antibody therapeutics.

  2022cites this paper
• NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products

  2021cites this paper
• Quo Vadis qNMR?

  2020cites this paper
• One- and two-dimensional NMR techniques

  2020cites this paper
• An NMR Based Similarity Metric for Higher Order Structure Quality Assessment among U.S. Marketed Insulin Therapeutics.

  2020cites this paper
• Analysis of Megavariate Data in Functional Omics

  2020cites this paper
• Analysis of Megavariate Data in Functional Omics q

  2020cites this paper
• Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation

  2020cites this paper
• Comparative Analysis of 1D PROFILE and 2D 1H,13C Methyl NMR Methods for Characterization of the Higher Order Structure of IgG1 Monoclonal Antibodies.

  2020cites this paper
• Assessment of the Higher‐Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis

  2020cites this paper
• Multi Way Classification

  2020cites this paper
• Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications

  2020cites this paper
• The metaRbolomics Toolbox in Bioconductor and beyond

  2019cites this paper
• Selective suppression of excipient signals in 2D 1H–13C methyl spectra of biopharmaceutical products

  2018cites this paper
• Platform development for expression and purification of stable isotope labeled monoclonal antibodies in Escherichia coli

  2018cites this paper